Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Chronic heart failure gets EMA approval

  • Comment

A drug has been approved for the treatment of chronic heart failure by the European Medicines Agency.

Ivabradine (Procoralan), which was already licensed for treating angina, has now also been approved for chronic heart failure - though it has yet to be approved for use in the NHS by the National Institute for Health and Clinical Excellence (NICE).

British Heart Foundation senior cardiac nurse Maureen Talbot said: “having another option to offer those patients whose condition is particularly difficult to treat is really positive news”.

She added: “Patients whose heart failure symptoms are already well controlled with their current treatment are unlikely to have their medication changed because of this new drug, but for many it could improve their quality of life.”

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs